DCMIC
Decheng Capital Management III (Cayman) Portfolio holdings
AUM
$300M
This Quarter Return
-10.5%
1 Year Return
+15.94%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$300M
AUM Growth
+$300M
(-6%)
Cap. Flow
+$37.4M
Cap. Flow
% of AUM
12.49%
Top 10 Holdings %
Top 10 Hldgs %
79.17%
Holding
32
New
7
Increased
1
Reduced
2
Closed
6
Top Buys
| 1 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$76.8M |
| 2 |
Roivant Sciences
ROIV
|
$17M |
| 3 |
Aura Biosciences
AURA
|
$13.6M |
| 4 |
Lantheus
LNTH
|
$9.88M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
$6.6M |
Top Sells
| 1 |
ALP.PRN
ALABAMA PWR 5.20% CL-A PRF
ALP.PRN
|
$69M |
| 2 |
APGN
Apexigen, Inc. Common Stock
APGN
|
$814K |
| 3 |
Adicet Bio
ACET
|
$418K |
| 4 |
NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
|
$92.5K |
| 5 |
SLRN
ACELYRIN
SLRN
|
$62K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Adicet Bio
ACET
$61.6M
| $274K | 0.09% |
200,201
-305,467
| -60% | -$418K |
|
|
NBSE
27
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| – | – |
-50,000
| Closed | -$92.5K |
|
|
APGN
28
DELISTED
Apexigen, Inc. Common Stock
APGN
| – | – |
-1,894,551
| Closed | -$814K |
|
|
ALP.PRN
29
DELISTED
ALABAMA PWR 5.20% CL-A PRF
ALP.PRN
| – | – |
-6,708,288
| Closed | -$69M |
|